product
Intellia Therapeutics (NTLA) Is Down 12.1% After Positive Phase 3 Lonvo-z Data And 2027 Launch Plans
Intellia reported positive Phase 3 data for its Lonvo-z therapy with 2027 launch plans, though the stock fell 12.1%.
Markets open original ↗
Importance is a model-assigned 1–5 on published stories, not a market forecast.
Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.
An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.
Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.
Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.
A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.
Mon · 12 Oct · today
Tue · 13 Oct
Fri · 10 Jul
product
Intellia reported positive Phase 3 data for its Lonvo-z therapy with 2027 launch plans, though the stock fell 12.1%.
Markets open original ↗
partnership
MDA Space agreed to acquire a 70% stake in CLS and raised $712 million to help fund the deal.
Markets open original ↗
regulation
Astellas and Pfizer's Padcev-Keytruda combination won broader FDA approval in bladder cancer.
Markets open original ↗
product
Astellas deployed the Boltz-2 NIM structure-prediction AI tool to accelerate its drug discovery process.
Markets open original ↗
partnership
Dassault and Tata are building a plant in Hyderabad to produce two Indian Rafale jets per month.
Markets open original ↗